JF
Jessica Fye JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Legend Biotech
LEGN
$6.66B
| $36.08 | $78 |
116%
upside
| Overweight | 13 days ago |
|
2
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $49 |
20%
downside
| Neutral | 13 days ago |
|
3
Incyte
INCY
$16.9B
| $86.64 | $73 |
16%
downside
| Neutral | 16 days ago |
|
4
Insmed
INSM
$30.7B
| $145.10 | $135 |
7%
downside
| Overweight | 18 days ago |
|
5
Ascendis Pharma
ASND
$12.5B
| $205.91 | $260 |
26%
upside
| Overweight | 19 days ago |
|
6
Halozyme
HALO
$8.76B
| $74.93 | $63 |
16%
downside
| Neutral | 1 month ago |
|
7
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $475 |
5%
upside
| Overweight | 1 month ago |
|
|
ONC
8
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.6B
| $341.80 | $345 |
1%
upside
| Overweight | 1 month ago |
|
9
Vertex Pharmaceuticals
VRTX
$102B
| $396.12 | $517 |
31%
upside
| Overweight | 1 month ago |
|
10
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $113 |
96%
upside
| Overweight | 1 month ago |
|
11
United Therapeutics
UTHR
$18.1B
| $400.52 | $330 |
18%
downside
| Overweight | 2 months ago |
|
12
Moderna
MRNA
$9.78B
| $25.14 | $26 |
3%
upside
| Underweight | 3 months ago |
|
13
BioNTech
BNTX
$27B
| $112.46 | $116 |
3%
upside
| Neutral | 3 months ago |
|
14
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.27 | $13 |
57%
upside
| Overweight | 4 months ago |
|
15
Immunocore
IMCR
$1.87B
| $37.20 | $50 |
34%
upside
| Overweight | 4 months ago |
|
16
NovoCure
NVCR
$1.37B
| $12.28 | $28 |
128%
upside
| Neutral | 5 months ago |
|
17
Jazz Pharmaceuticals
JAZZ
$7.86B
| $129.50 | $209 |
61%
upside
| Overweight | 6 months ago |
|
18
Denali Therapeutics
DNLI
$2.26B
| $15.43 | $24 |
56%
upside
| Overweight | 8 months ago |
|
19
Alkermes
ALKS
$4.94B
| $29.94 | $26 |
13%
downside
| Neutral | 10 months ago |
|
|
MBX
20
MBX Biosciences, Inc. Common Stock
MBX
$388M
| $11.55 | $30 |
160%
upside
| Overweight | 11 months ago |
|
21
Crinetics Pharmaceuticals
CRNX
$3.35B
| $35.61 | $54 |
52%
upside
| Overweight | 1 year ago |
|
22
Mirum Pharmaceuticals
MIRM
$3.82B
| $76.06 | $39 |
49%
downside
| Overweight | 1 year ago |
|
23
Stoke Therapeutics
STOK
$1.13B
| $20.68 | $13 |
37%
downside
| Neutral | 1 year ago |
|
24
Lexicon Pharmaceuticals
LXRX
$396M
| $1.09 | $7 |
542%
upside
| Neutral | 4 years ago |
|